Management of Hyperkalaemia (Potassium Binders)
A common barrier to heart failure treatment is high potassium levels, which often force doctors to stop life-saving MRA and ARNI therapy. In 2026, the use of Potassium Binders (Patiromer and Sodium Zirconium Cyclosilicate) has become a "bridge" to keep patients on their heart medications.
Instead of stopping the heart drugs, doctors now prescribe these binders to safely lower potassium. This "enabling" strategy allows more patients to stay on the full "Four Pillars" of therapy even if they have moderate kidney disease.
1 View